Custommune

Custommune provides personalized immunotherapies to induce long-term disease remission in HIV and cancer patients.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location São Paulo, State of São Paulo, Brazil
  • Currency USD
  • Founded March 2020
  • Employees 5
  • Incorporation Type Not Incorporated
  • Website custommune.me

Company Summary

Custommune provides immunotherapies to induce long-term remission in HIV and cancer patients. Its pipeline supplies researchers with a flexible, yet affordable platform to design tailored therapeutics.
The Custommune algorithm is the subject of a patent application and is being tested in a phase-II clinical trial of anti-HIV personalized vaccination, also, pre-clinically for the development of COVID-19 vaccine and bladder-cancer immunotherapy.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free